wideout , Yes the scientists and the science have done an estonishing job especially obtaining the BTD, with limited resources, limited finances and no BP support over the past 20 years.  However the business side and development  has been amateur at best as company with this BTD FDA award any properly run small biotech should not be trading at 150 million USD!!   If the proper business development would had been done, rvx would have got a large investment banking co to do a nasdaq listing and market this BTD accomplishment to larger US retail markets. I suppose RVX expected BETONOMACE to succeed and be sold off in late 2019 but now with the BTD you would think several BP would have been knocking down the door to take ownership of this newly excitingup and coming  epigentics small biotech.  I don't give credit to DM to continue moving the ball down the field with continued financing over the past several years as those in the know, ie hepalink, oristar and other know what bright future epigenetics and a company with a BTD is worth, and it is worth a ton more than $1 usd financing.  lets just hope we can finally get to a conclusiona large BP deal after all these years and promises.   Tomorrow will be interesting GLTA